Eli Vlaisavljevich
Papers
3
Total Citations
155
H-Index
3
About
Eli Vlaisavljevich is a pioneering biomedical engineer whose research focuses on the development of noninvasive, nonthermal ultrasound therapies, most notably histotripsy. His work centers on harnessing focused ultrasound to mechanically destroy tissue through cavitation, offering a precise alternative to thermal ablation for cancer treatment. As a key contributor to the field, he has led groundbreaking studies on robotically assisted sonic therapy (RAST), demonstrating its feasibility for creating clinically relevant hepatic ablations capable of treating liver tumors. His most cited paper (90 citations) established the proof of concept for RAST in a porcine liver model, while subsequent work (44 citations) addressed critical challenges like mitigating body wall damage through modified pulse sequences. His research on transcostal histotripsy ablation (21 citations) further expanded the technique's applicability. With a growing portfolio of highly cited publications, Vlaisavljevich has positioned himself as a leader in advancing histotripsy toward clinical translation, with his work directly impacting the future of noninvasive cancer surgery and solidifying his reputation as an innovator in therapeutic ultrasound.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Transcostal Histotripsy Ablation in an In Vivo Acute Hepatic Porcine Model21 citations · 2021